Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $110
Portfolio Pulse from richadhand@benzinga.com
Citigroup analyst Joanne Wuensch maintains a Buy rating on Edwards Lifesciences (NYSE:EW) and raises the price target from $101 to $110.
July 11, 2023 | 2:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Citigroup maintains a Buy rating on Edwards Lifesciences and raises the price target from $101 to $110.
The raised price target by Citigroup indicates a positive outlook for Edwards Lifesciences. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100